Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
149.23
-6.46 (-4.15%)
At close: Jun 5, 2026, 4:00 PM EDT
149.00
-0.23 (-0.15%)
After-hours: Jun 5, 2026, 7:58 PM EDT
Revolution Medicines Market Cap
Revolution Medicines has a market cap or net worth of $31.73 billion as of June 5, 2026. Its market cap has increased by 339.66% in one year.
Market Cap
31.73B
Enterprise Value
30.25B
1-Year Change
339.66%
Ranking
Category
Stock Price
$149.23
Market Cap Chart
Since February 13, 2020, Revolution Medicines's market cap has increased from $1.64B to $31.73B, an increase of 1,829.23%. That is a compound annual growth rate of 59.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 31.73B | 106.04% |
| Dec 31, 2025 | 15.40B | 90.50% |
| Dec 31, 2024 | 8.08B | 71.26% |
| Dec 29, 2023 | 4.72B | 123.15% |
| Dec 30, 2022 | 2.11B | 14.03% |
| Dec 31, 2021 | 1.85B | -29.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 13, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Regeneron Pharmaceuticals | 64.65B |
| argenx SE | 55.01B |
| Alnylam Pharmaceuticals | 40.46B |
| Royalty Pharma | 32.17B |
| BeOne Medicines AG | 30.03B |
| BioNTech SE | 22.27B |
| Roivant Sciences | 20.56B |
| Incyte | 20.45B |